Werner Lanthaler
Director/Board Member en AC IMMUNE SA .
Fortuna: 24 M $ al 31/03/2024
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Andrea Pfeifer | M | 66 | 21 años | |
Mario Polywka | M | 61 | 20 años | |
Douglas Williams | M | 66 | 6 años | |
Craig Johnstone | M | 54 |
Evotec (UK) Ltd.
Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The private company is based in Abingdon, UK and was founded in 1991. | 12 años |
Iris Löw-Friedrich | M | 63 | 10 años | |
Anthony Adam Rosenberg | M | 71 | 7 años | |
Monika Bütler | M | 63 | 3 años | |
Oliver Sol | M | 58 | 8 años | |
Monica Shaw | M | 46 | 3 años | |
Ana Cespedes | M | 51 | 2 años | |
Christopher Roberts | M | 35 | 5 años | |
Roy Ervin Twyman | M | 68 | 5 años | |
Beth Delgiacco | F | - | 6 años | |
Camilla Sylvest | F | 52 | 2 años | |
Piergiorgio Donati | M | 54 | 6 años | |
Steve Krognes | M | 56 | 1 años | |
James Daly | M | 63 | 6 años | |
Jean-Fabien Monin | M | 54 | 15 años | |
Carl June | M | 70 | 4 años | |
Pamela Klein | M | 63 | 8 años | |
Gary Waanders | M | 60 | - | |
Joseph deBethizy | M | 74 | 9 años | |
Laetitia Rouxel | F | 51 | 1 años | |
Matthias Evers | M | 51 | 2 años | |
Hemamalini Moorthy | F | 54 | 2 años | |
Constanze Ulmer-Eilfort | M | 62 | 3 años | |
Filip Borgions | M | - | 9 años | |
Hinnerk Rohwedder | M | - | 3 años | |
Luc Truyen | M | 59 | 2 años | |
Peter Ulrichts | M | 44 | 1 años | |
Mark Danton | M | 60 | 5 años | |
Julian Snow | M | - | - | |
Howard Donovan | M | 49 | 2 años | |
Karl Gubitz | M | 54 | 3 años | |
Ralph Spillner | M | 54 |
Evotec (UK) Ltd.
Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The private company is based in Abingdon, UK and was founded in 1991. | - |
Bojana Portmann | M | 43 | 13 años | |
Marc Schorpion | M | 66 | 6 años | |
Arjen Lemmen | M | 39 | 8 años | |
Julien Rongère | M | 47 | 7 años | |
Alexandre Caratsch | M | 59 | 6 años | |
Christophe Muller | M | 53 |
Evotec (UK) Ltd.
Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The private company is based in Abingdon, UK and was founded in 1991. | - |
Camilla Languille | F | 41 | 2 años | |
Elaine Sullivan | M | 63 | 9 años | |
Madiha Derouazi | M | 51 | - | |
Sonia Maria Poli | M | 59 | 7 años | |
Wolfgang Barth | M | - | - | |
Kari Kapsch | M | 60 |
Federation of Austrian Industry
Federation of Austrian Industry Miscellaneous Commercial ServicesCommercial Services The Federation of Austrian Industry is an organization that focuses on the observation and analysis of international developments, trade and investment agreements, and the conditions of fair international competition. The non-profit company is based in Vienna, Austria. Austria is a small but highly export-oriented economy, and the organization believes that for the future growth and prosperity of the country, its companies must have the best possible framework to take advantage of their international opportunities. The organization emphasizes the importance of sustainable international relationships and free and fair trade to ensure Austria's export capability and access to markets. The CEO of the Austrian company is Martin Ohneberg. | 25 años |
Cord Dohrmann | M | 60 | 14 años | |
Roland Sackers | M | 56 | 5 años | |
Nuno Mendonça | M | 42 | 1 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Eric Castaldi | M | 59 | 7 años | |
Martin Velasco | M | 70 | 18 años | |
Reinhard Kandera | M | 54 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 12 años |
Timm H. Jessen | M | 62 |
Topas Therapeutics GmbH
Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany. | 5 años |
Thomas Lingelbach | M | 60 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 7 años |
Peter Bollmann | M | 71 | 6 años | |
Thomas Graney | M | 60 | 7 años | |
David Lacey | M | 71 | 7 años | |
Wolfgang Plischke | M | 72 | 7 años | |
Charmion Gillmore | F | - | - | |
Claus Tycho Bræstrup | M | 79 | - | |
Walter Wenninger | M | 86 | 6 años | |
Michel Gréco | M | 80 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 10 años |
Bernd Hirsch | M | 53 | - | |
Mustapha Bakali | M | 62 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 6 años |
James Sulat | M | 73 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 8 años |
Friedrich von Bohlen und Halbach | M | 60 | 5 años | |
Paul Herrling | M | 78 | 3 años | |
Alan Colowick | M | 61 | - | |
Michael Shalmi | M | 59 | - | |
Dirk Beeusaert | M | 59 | 5 años | |
Andreas Pinkwart | M | 64 | 3 años | |
Nicolas Leupin | M | 50 | 3 años | |
Corey Goodman | M | 72 | 2 años | |
Kasim Kutay | M | 59 | - | |
Paul Sekhri | M | 65 |
Topas Therapeutics GmbH
Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany. | - |
R. Woods | M | 57 | 5 años | |
Wim Parys | M | 64 | 3 años | |
Cony D’Cruz | M | 62 | 9 años | |
Klaus Martin | M | - |
Topas Therapeutics GmbH
Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany. | - |
Johannes Streffer | M | 56 | 2 años | |
Monika Conradt | F | - | - | |
Yvonne Greenstreet | M | 61 | 1 años | |
Andreas Muhs | M | 62 | 13 años | |
Enno Spillner | M | 55 | 7 años | |
Peter John Fellner | M | 80 | 6 años | |
Michael Bart Sheffery | M | 73 | - | |
Gregory Glenn | M | 70 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 2 años |
Harrold van Barlingen | M | 58 | 7 años | |
Veit Sorger | M | 81 |
Federation of Austrian Industry
Federation of Austrian Industry Miscellaneous Commercial ServicesCommercial Services The Federation of Austrian Industry is an organization that focuses on the observation and analysis of international developments, trade and investment agreements, and the conditions of fair international competition. The non-profit company is based in Vienna, Austria. Austria is a small but highly export-oriented economy, and the organization believes that for the future growth and prosperity of the country, its companies must have the best possible framework to take advantage of their international opportunities. The organization emphasizes the importance of sustainable international relationships and free and fair trade to ensure Austria's export capability and access to markets. The CEO of the Austrian company is Martin Ohneberg. | - |
Colin Bond | M | 64 | 6 años | |
Jeffrey Farrow | M | 62 | 2 años | |
Marie Kosco-Vilbois | M | 67 | 5 años | |
Mary C. Tanner | F | 73 | 9 años | |
John Paul de Koning | M | 55 | 8 años | |
Gerd Zettlmeissl | M | 68 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 10 años |
Tim Tasker | M | 70 | - | |
Roland Oetker | M | 75 | 3 años | |
David Ebsworth | M | 69 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 8 años |
Leesa Gentry | F | 54 | 13 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Alemania | 34 | 34.00% |
Suiza | 29 | 29.00% |
Países Bajos | 25 | 25.00% |
Austria | 10 | 10.00% |
Reino Unido | 3 | 3.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Werner Lanthaler
- Red Personal